Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
116,479
-
Share change
-
+16,068
-
Total reported value
-
$150,922
-
Price per share
-
$1.30
-
Number of holders
-
11
-
Value change
-
-$39,581
-
Number of buys
-
8
-
Number of sells
-
4
Institutional Holders of Protagenic Therapeutics, Inc.new - COM (PTIX) as of Q4 2025
As of 31 Dec 2025,
Protagenic Therapeutics, Inc.new - COM (PTIX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
116,479 shares.
The largest 10 holders included
DRW Securities, LLC, FNY Investment Advisers, LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES FINANCIAL INC, Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., BANK OF AMERICA CORP /DE/, United Financial Planning Group LLC, and MORGAN STANLEY.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.